Skip to main content
OpenTrials

Clinical trial condition

Bronchial Neoplasms

Explore clinical trials studying Bronchial Neoplasms. Study availability and eligibility vary by location and protocol.

5,269 public trials 1,194 recruiting studies
Refine in advanced search Browse all conditions

Bronchial Neoplasms trial results

Completed

Galinpepimut-S in Combination With Pembrolizumab in Patients With Selected Advanced Cancers

NCT03761914

Conditions
Acute Myelogenous Leukemia, Adnexal Diseases, Breast Diseases, +45 more
Locations
  • St. Joseph Heritage Healthcare Santa Rosa, California, United States
  • Innovative Clinical Research Institute (ICRI) Whittier, California, United States
  • Miami Cancer Institute at Baptist Health, Inc. Miami, Florida, United States
  • Memorial Sloan Kettering Cancer Center Basking Ridge, New Jersey, United States
View Trial Details
Completed

Phase 1 Dose Escalation Study for VIP236 in Patients With Advanced Cancer

NCT05712889

Conditions
Adnexal Diseases, Biliary Tract Diseases, Biliary Tract Neoplasms, +43 more
Locations
  • Honor Health Scottsdale, Arizona, United States
  • NEXT Austin Austin, Texas, United States
  • NEXT Oncology San Antonio San Antonio, Texas, United States
  • Macquarie University Macquarie Park, New South Wales, Australia
View Trial Details
Completed

Phase I Dose Escalation Study for VIP152 in Patients With Advanced Cancer

NCT02635672

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +65 more
Locations
  • Highlands Oncology Group Springdale, Arkansas, United States
  • Norton Cancer Institute Louisville, Kentucky, United States
  • Maryland Oncology Hematology Silver Spring, Maryland, United States
  • John Theurer Cancer Center Hackensack, New Jersey, United States
View all 16 locations
View Trial Details
Completed

A Dose Escalation Study of ASP8273 in Subjects With Non-Small-Cell Lung Cancer (NSCLC) Who Have Epidermal Growth Factor Receptor (EGFR) Mutations

NCT02113813

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • Site US10010 Washington D.C., District of Columbia, United States
  • Site US10006 Baltimore, Maryland, United States
  • Site US10012 Boston, Massachusetts, United States
  • Site US10001 Boston, Massachusetts, United States
View Trial Details
Completed

Small Cell Lung Carcinoma Trial With Nivolumab and IpiliMUmab in LImited Disease

NCT02046733

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Diabetes Mellitus, Insulin-Dependent, 12, +10 more
Locations
  • Bendigo Hospital Bendigo, Australia
  • Coffs Harbour Health Campus Coffs Harbour, Australia
  • Royal Brisbane and Women's Hospital (QLD) Herston, Australia
  • Royal Hobart Hospital Hobart, Australia
View all 61 locations
View Trial Details
Completed

TEIPP Immunotherapy in Patients With NSCLC

NCT05898763

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Leiden University Medical Center Leiden, South Holland, Netherlands
  • Erasmus Medical Center Rotterdam, South Holland, Netherlands
View Trial Details
Completed

Phase II AZD9291 Open Label Study in NSCLC After Previous EGFR TKI Therapy in EGFR and T790M Mutation Positive Tumours

NCT02094261

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Research Site La Jolla, California, United States
  • Research Site Orange, California, United States
  • Research Site New Haven, Connecticut, United States
  • Research Site Norwalk, Connecticut, United States
View all 44 locations
View Trial Details

Related conditions